$2.35B
$359,000
0.0% of portfolio
7,963
Q2 2024
Reduced 5.75%
$1.52B
$3.41 Million
0.0% of portfolio
220,707
Q2 2024
Added 1,048.02%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 58.91%
-
$0
0.0% of portfolio
-
Q2 2024
Added 74.17%
$3.2B
$377,000
0.0% of portfolio
2,595
Q2 2024
Added 3.18%
$8.48B
$4.34 Million
0.0% of portfolio
35,051
Q2 2024
Added 0.4%
$64.4B
$735,000
0.0% of portfolio
25,371
Q2 2024
Added 2.3%
-
$0
0.0% of portfolio
-
Q1 2023
Reduced 35.07%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 71.33%
$573M
$2.65 Million
0.0% of portfolio
367,150
Q2 2024
Added 0.14%
$3.17B
$1.22 Million
0.0% of portfolio
73,629
Q2 2024
Added 91.23%
$164M
$65,000
0.0% of portfolio
51,201
Q1 2024
Reduced 41.28%
$2.46B
$243,000
0.0% of portfolio
3,305
Q2 2024
Added 0.92%
$3.66B
$478,000
0.0% of portfolio
11,391
Q2 2024
Reduced 0.88%
$78.7B
$3.9 Million
0.0% of portfolio
136,581
Q2 2024
Added 7.4%
$1.92B
$9.04 Million
0.0% of portfolio
1,727,870
Q2 2024
Added 17.79%
$15.1B
$1.29 Million
0.0% of portfolio
31,524
Q2 2024
Reduced 38.22%
$5.38B
$695,000
0.0% of portfolio
53,562
Q2 2024
Reduced 82.6%
$2.22B
$7.08 Million
0.0% of portfolio
364,918
Q2 2024
Added 14.68%
$24.1B
$3.27 Million
0.0% of portfolio
9,033
Q2 2024
Added 85.75%
$5.94B
$548,000
0.0% of portfolio
5,810
Q2 2024
Added 1.75%
$3.1B
$257,000
0.0% of portfolio
2,453
Q2 2024
Added 0.04%
$127M
$954,000
0.0% of portfolio
429,852
Q2 2024
Added 744.5%
$6.86B
$538,000
0.0% of portfolio
9,586
Q2 2024
Reduced 4.75%
$4.67B
$1.83 Million
0.0% of portfolio
66,108
Q2 2024
Added 30.17%
$0
$32,000
0.0% of portfolio
794
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 10.65%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 36.8%
-
$0
0.0% of portfolio
-
Q2 2024
New
$0
$80,000
0.0% of portfolio
1,918
Q2 2024
Added 108.93%
$0
$6,000
0.0% of portfolio
125
Q1 2023
Reduced 17.6%
$0
$3,000
0.0% of portfolio
122
Q2 2024
Reduced 0.81%
-
$0
0.0% of portfolio
-
Q2 2024
Added 3,178.13%
$0
$4.4 Million
0.0% of portfolio
224,030
Q2 2024
Added 51.19%
-
$0
0.0% of portfolio
-
Q2 2024
Added 8.54%
$0
$51,000
0.0% of portfolio
2,700
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 78.0%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 20.84%
Eupraxia Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$4.91B
$1.27 Million
0.0% of portfolio
12,261
Q2 2024
Reduced 6.28%
$315M
$204,000
0.0% of portfolio
5,863
Q2 2024
New
$240M
$403,000
0.0% of portfolio
83,458
Q2 2024
Reduced 0.53%
$0
$5.12 Million
0.0% of portfolio
146,323
Q2 2024
Reduced 38.47%
$2.2B
$1.17 Million
0.0% of portfolio
35,084
Q2 2024
Added 1.1%
$11.6B
$4.92 Million
0.0% of portfolio
116,496
Q2 2024
Reduced 47.54%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 28.13%
-
$0
0.0% of portfolio
-
Q1 2024
New
$0
$254,000
0.0% of portfolio
16,700
Q2 2024
Reduced 36.01%
$0
$320,000
0.0% of portfolio
25,966
Q2 2024
New
$0
$1.53 Million
0.0% of portfolio
27,818
Q2 2024
Added 715.78%